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Introduction
　Recently, the role of bio-markers has been changing, such 
as for identifying theranostics or TAT(turn-around-time) di-
agnosis. Cancer growth and development is associated with 
stimulation of oncogenic signal pathways, including en-
hanced interleukin 2-receptor (IL-2R) expression in T-cells 
and its shedding into the circulation in a soluble form of IL-
2Ralpha(1,2,3). In 1994, we identified elevated levels of 
sIL-2R even in healthy HTLV-1 seropositive carriers,whereby 
the presence of ATL became overt once levels attained 
1000u/mL(4). Recently, elevated sIL-2R levels have been 
reported not only in lymphoid tumors but also in cancers, 
and degenerative and unknown disorders(5,6).　Moreover, 
tumor-infiltrating lymphocytes involved in anti-immunity 
also are likely to be associated with sIL-2R(7).　Also, there 
is a new attractive theory on the interaction of the sIL-2R/
IL-2 complex with the heterogeneous clinical course in fol-
licular lymphoma(8). Of interest, the most common mature 
lymphomas, diffuse large B-cell lymphoma (DLBCL)- and 
Follicular lymphoma (FL)-cells, have been reported to ex-
press CD25 (9,10).Lactate Dehydrogenase (LDH) is also a 
MS#AMN 07170
Quantitative Features of serum sIL-2R level in Patients with Mature B-Cell 
Lymphoma– Involvement of LDH
Reiko MatsuMoto1), shimeru KaMihiRa1,2), Takashi MatsubaRa1), Shouichi YaMada1), Kazuyuki Matsuda1), 
Kazuhisa Kinoshita1), Youichi taKahashi1), Takashi KaneMatsu 1,2), Kazuhisa naKashiMa1), and Charles de Kerckhove1,2). 
1) Nagasaki Harbor Medical Center(NHMC)
2) Inovation & Translational Research Center (ITREC)
　Serum Lactate Dehydrogenase (LDH) activity and soluble IL-2 Receptor-alpha (sIL-2R) levels are monitored as a marker of 
disease activity in patients with lymphoma. Although adult T-cell leukemia (ATL) cells are well known to release large amounts of 
sIL-2R,it remains unclear to what extent B-cell lymphoma cells shed sIL-2R in sera. Subtypes of mature B-cell lymphoma, includ-
ing CD25+ hairy leukemic cells, were examined for the characteristics of sIL-2R levels in each subtype. In normal controls, the 
serum sIL-2R mean value was 260u/mL.The median serum sIL-2R value for 64 B-cell lymphoma cases was 506 u/mL;by subtype 
the median values were as follows: 1157 u/mL for 7 cases of chronic lymphocytic leukemia/hairy cell leukemia (CLL/HCL), 451 
u/mL for 38 cases of diffuse large B-cell lymphoma (DLBCL), and 456 u/mL for 19 cases of follicular Lymphoma (FL). The me-
dian values of serum LDH activity by the above subtypes were 175 IU/mL, 204 IU/mL, and 198 IU/mL, respectively. There was 
distinct inter-subtype and inter-patient variation of serum sIL-2R.In particular, inter-case variation could be grouped into value for 
three concentration ranges: less than 300 u/mL, 300-1000 u/mL, and greater than 1000 u/mL. Cases with serum sIL-2R values 
of 1000 u/mL or more tended to have an especially high sIL-2R to LDH ratio, suggesting a close relationship between high sIL-2R 
and CD25-expressing lymphoma cells. With respect to sIL-2R and LDH levels, CLL/HCL, DLBCL, and FL showed similar distri-
butions. Moreover, for sIL-2R levels exceeding 1000u/mL, sIL-2R levels were randomly high according to the LDH status. Con-
clusively, the combination of serum sIL-2R level and LDH activity can provide a better understanding of characteristics of sub-
types of mature B-Cell Lymphoma and can be used as a reliable surrogate marker for evaluating numerical and biological data.
 ACTA MEDICA NAGASAKIENSIA 60: 33−37, 2016
Key words: sIL-2R, bio-marker, RI, B-ML
　 　
Address correspondence: Shinchi 6-39, Nagasaki, Japan, 852-5555
Tel: +81-(95)-822-3251; Fax: +81-(95)-826-8798; E-mail: kamihira_Shimeru@ncho.jp
Received Nobember 25, 2014; Accepted March 2, 2015
34 Shimeru Kamihira et al.: Closed Relation of Compensatory LDH and sIL-2R
useful biomarker for lymphoma oncology(11). Most cancer 
cells use aerobic glycolysis to fuel their growth via pyruvate 
to lactate by LDH. Although the molecular mechanism has 
been elusive, the ability of malignant cells to overproduce 
lactic acid was recognized about seven decades ago. In-
creases in glucose transport and hexokinase activity in ma-
lignant cells appear to account for the increase flux of trans-
port through the malignant cells (12). Accordingly, based on 
our experience of ATL and CD25 bearing T-cells(13,14), we 
evaluated the relationship between serum sIL-2R level and-
serum LDH activityin subtypes of mature B-cell leukemia/
lymphoma.
Methods and Material
　Study design: Our study s̓ subjects were healthy Nagasaki 
City employees as normal controls and patients diagnosed by 
lymph node biopsy. The results were evaluated by numerical 
analysis only. In general, a high numerical laboratory value 
implies the presence of lymphomas̓ characteristic features; 
therefore, normal controls to produce a reference interval 
(RI) were collected from the Nagasaki City employees, whose 
samples were brushed-upby HTLV-1, LDH, and CRP test 
data. Samples taken from 3 HTLV-1seropositive persons, 16 
high LDH samples, and 29 high CRP samples were discard-
ed. Ages ranged from 20 to 65 with a mean of 45.8 years.
　sIL-2R was measured at our hospital by a commercially 
available kit manufactured by Siemens Healthcare Di-
agnostics, Tokyo, Japan. Histological diagnosis was conduct-
ed at the Center for Diagnostic Imaging in Kurume, Japan. 
　The B-cell lymphomas of the patient subjects included-
classical chronic lymphocytic leukemia/hairy cell leukemia
(CLL/HCL), diffuse large-B cell lymphoma (DLBCL), and 
follicular lymphoma (FL). The software used for statistical 
analysis was StatFlex version 6.0 (Osaka, Japan).
Results
●　Age-related study design of sIL-2R
　First, as IL-2R level increase of 18% (239 u/mL – 283 u/
mL) was observed　across five decades in adulthood from 
the 20s to the 60s in normal controls brushed-up. No sIL-2R 
measurements were below 150 u/mL (Figure 1, see red bro-
ken line). However, the upper limit measurements increased 
from 300 u/mL in the 20s to 450 u/mL in the 40s, as de-
noted by the yellow box. The RI calculation resulted in a 
median value of 260±41 u/mL, at the age of 46.2 years.  
●　General status of serum sIL-2R in mature B-ML
　We conducted a cross-sectional examination of serum 
sIL-2R levels and serum LDH activity across all cases. In 
contrast to the extremely high sIL-2R levels in ATL, for all 
64 mature B-ML cases the highest sIL-2R value was at most 
4000u/mL and the median serum sIL-2R level was only 
506u/mL.Figure 2 is a histogram showing each individual 
patientʼs levels of sIL-2R and LDH, in ascending order of 
sIL-2R level. Nine B-ML samples had a lower sIL-2R value 
than 260u/mL, the normal RI. The 300 u/mL to 1000 u/mL 
range showed a continuous increase in level values, but the 
range above 1000 u/mL showed more random step-like in-
creases. This suggests a substantial transition in sIL-2R ki-
netics around 1000 u/mL.To confirm significance of this 
apparent critical line, a single argument dot graph juxtapos-
ing cases by ascending sIL-2R and LDH levels was evalu-
ated (Figure 3). As of the 1000 u/mL critical threshold, such 
discontinuous events were observed in the sIL-2R levels 
(red solid circle array), but not immediately in the LDH 
levels(blue solid circle array) until further along the x-axis.
In spite of poor statistical correlation between sIL-2R and 
LDH (R2=0.0917, slope=0.0041), juxtaposing cases by as-
cending sIL-2R and LDH levels suggests a positive associa-
tion with identifiable similarities.
●　Features of subtype of B-ML
　We examined whether there is a difference between the 2 
biomarkers among the 3 subtypes of mature B-ML.The 
stair-like step-up pattern was also observed in the subtypes 
(Figure 4), where the median sIL-2R values for CLL/HCL, 
DLBCL, and FL subtypes were 1157, 451, and 456, respec-
Figure 1. Age-related reference intervals for serum sIL-2R (para-
metric estimate)
Fig. 1－Process of Brush-up for Subjects－
 Symptomatic condition
 Discarded samples
HTLV-1-positive : 3 cases (anti-HTLV-1 (+)
high LDH             : 16 cases (225<)
high CRP : 29 cases (0.1<)  
























Figure 1. Age-related reference intervals for serum sIL-2R (parametric estimate)
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tively (differences between CLL/HCL group vs DLBCL 
and FL groups significant by Mann-Whitney)； Table 1.The 
critical line was considered to be about 1100u/mL in CLL/
HCL, and about 450u/mL in DLBCL and FL. The median 
values of serum LDH activity by the above subtypes were 
175 IU/mL, 204 IU/mL, and 192 IU/mL, respectively. Of 
interest, cases with sIL-2R values of 1000 or more tended to 
be separated in two groups:high sIL-2R with or without 
high LDH activity (Figure 5). Table 2 summarizes the char-
acteristics of the 3 subtypes examined by the present study.
In examining the 3 subtypes by the ratio of sIL-2R/LDH, it 
appeared as if CLL/HCLcould be distinguished from the 
two other subtypes DLBCL and FL.
Figure 2. Histograph arranged in descending order of sIL-2R 
measurements. Blue bar(sIL-2R) beomes high from 142 u/mL and 
then gradually are being come up.Exceeded 1000u/mL line, their 
randomly becomes higher. (Red bar; LDH actiity)
Figure 4.  Histograms in each subtype. The association  of individual sIL-2R(Blue bar) and LDH (Red bar)  among the subtypes. sIL-2R levels were  
classified into three density groups; less than 300, 300 - 500, 500-1000 , and 1000 or more.
Panel (A) CLL and HCL (B) DLBCL
( C) FL
Figure 4. Histograms in each subtype. The association of individual sIL-2R(Blue bar) and LDH (Red bar) among 
the subtypes. sIL-2R levels were classified into three density groups; less than 300, 300 - 500, 500-1000 , and 
1000 or more.
Figure  3. A single argument dot-plot graph (Blue solid ;LDH, 
Red solid circle; sIL-2R). Two arraries changed after 
red solid line (1000 critical line).
1000
Critical line
Figure 3. A single argument dot-plot graph (Blue solid ;LDH,
Red solid circle; sIL-2R). Two arraries changed after red solid line 
(1000 critical line).
Table 1:All mature B-ML Subtypes and median values with per-
centiles
*; The median values of sIL-2R were almost same, but the distri-





















































CLL/HCL1157; other two;0.0001 (Mann-whitney)
2.07 significant vs 2.24&5.76（Mann-Whitney)
Figure 2. Histograph arranged in descending order of sIL-2R measurements. Blue bar
(sIL-2R) beomes high from 142 u/mL and then gradually are being come up. 
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Figure 2. Histograph arranged in descending order of sIL-2R measurements. Blue bar
(sIL-2R) beomes high from 142 u/mL and then gradually are being come up. 
Exceeded 1000u/mL line, their randomly becomes higher. Red bar:; LDH actiityIndividual sIL-2R and LDH data
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Discussion
　For a long time,much effort has been devoted to identify-
ing potential biomarkers for lymphoma. However, there do 
not appear to be indicators readily excelling LDH and sIL-
2R. The elevation of serum LDH activity and sIL-2R levels 
have been used for diagnosing, monitoring therapy, and pre-
dicting prognosis. 
　To precisely interpret clinical data in the present study, 
we established an RI in healthy controls because high sIL-
2R levels are not necessarily associated with any specific 
symptoms. For example, one healthy sample donor had a 
serum sIL-2R level of 860u/mL, suggesting some kind of 
occult condition. Such sampling results were omitted as 
outliers in establishing the RI.By this approach,we conclud-
ed that RI is age-related while establishing260±41u/mL as 
the median adulthood RI.
　Our fundamental interest is the applicability of sIL-2R as 
a laboratory test. Recently, the development of monoclonal 
antibodies defined the positive-expression of CD25 for many 
kinds of normal cells and cancer cells. Through flow-cyto-
metric studies, Yoshida et al(9) also reported the presence of 
CD25-positive expression induced by DLBCL- and FL-leu-
kemic cells. Interestingly, our studyʼs results have similari-
ties to those of Yoshida et al., with respect to the origins of 
sIL-2R.
　More recently, sIL-2R-related research has been advanced 
through the study of T-cell growth factors and Tac antigens 
by Uchiyama et al (16), where Tac was later designated as 
IL-2R alpha. Although the biological function is not yet 
completely understood, recently Yang Z-Z et al (8) reported 
that sIL-2R facilitates IL-2-mediated immune responses, 
showing the potential impact of sIL-2R on CD4+T-cell-me-
diated inhibition of CD8+T-cells.  The clinical application of 
sIL-2R, in general, is used as a surrogate marker of tumor 
burden in oncology. However, the extent by which serum 
level of sIL-2R reflects the degree of tumor burden differs by 
disease. For applicability to ATL, we found the potentiality 
to predict ATL development through longitudinal observa-
tion of sIL-2R.Furthermore, since this receptor appears to be 
influenced by a wide range of diseases, we expedites to use 
as a marker to attain some measure of university.
Clinical significance of double assays
 
for LDH and sIL-2R
　Both of the biomarkers discussed are considered to be 
equally useful in clinical practice of lymphoma. To our 
knowledge, there is no report about the possibility that the 
kinetics of sIL-2R may be modulated by LDH status, yet 
LDH is one of the major enzymes catalyzing the biochemi-
cal process of pyruvate to lactate conversion. Unfortunately, 
in this study, such research between sIL-2R and LDH was 
not performed. Our study was noteworthy in that elevated 
sIL-2R appeared to be affected by LDH status.
　Currently, LDH is widely employed in laboratory tests for 
clinical chemistry as a tumor or death marker. In contrast,the 


























Figure 5. Twin-dot plot graph between sIL-2R and LDH.
Exceeded 1000u/mL(broken black line), high sIL-2R group was divided into 
two groups, high sIL-2R group with high LDH (A-area) and without high LDH (B-area). 
Figure 5. Twin-dot plot graph between sIL-2R and LDH.
Exceeded 1000u/mL(broken black line), high sIL-2R group was 
divided into two groups, high sIL-2R group with high LDH (A-
area) and without high LDH (B-area).
Table 2. Characteristics of three subtypes of mature B-ML
features CLL/HCL DLBCL FL
sIL-2R u/ml (median) 1157 451 456
　　critical line 1500 1000 1000
LDH IU/ml (Median) 188 198 234
individual sIL-2R leve distribution
-299 0 8(21.6%) 6(31.2%)
　 300-499 1(14.3) 12(32.1%) 2(10.2%)
　 500-999 2(28.6%) 12(32.4%) 4(20.4%)
　1000-1499 1(14.3%) 0 5(26.3%)
　1500- 3(42.8%) 5(13.5%) 2(10.2%)
individul LDH activity distribution site
-225 5(71%) 26(70%) 8(42%)
　 226- 382 1(14%) 8(22%) 8(42%)
　 383-762 0 2(5%) 2
　 763-- 0 1(2%) 1
Ratio of sIL-2R/LDH 5.76 2.24 2.07
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eration. The pioneering translational research of the IL-2/
IL-2R signal mechanism has opened new windows into mo-
lecular biology, and clinical applications of IL-2R,as a re-
ceptor of various kinds of cells, include tumor marker func-
tionality. Thus, contrasting both biomarkersʼ progression is 
expected to promote biomarker applicability. The present 
study has not established direct correlations with respect to 
clinical oncological findings or explained origins of sIL-2R 
in terms of lymphoma cells alone;namely, if the elevation of 
sIL-2R is over 1000u/mL accompanied with high LDH, the 
high sIL-2R is thought to be derived from a tumor. In con-
trast, high sIL-2R with normal LDH is thought to be derived 
from the pathology ofan intra-tumor microenvironment.
　In conclusion,the present study discloses the following: 1) 
serum sIL-2R level inmature B-cell lymphomas is not very 
high, equivalent to that of 1/10 to 1/100 in ATL, 2) there is 
inter-case and inter-subtype variation of sIL-2R level, that is, 
since an individualʼs sIL-2R level can fall within anormal 
healthy limit, above the 1000 u/mL critical threshold, or 
within the 300 to 1000 u/mL middle range, a serumsIL-2R 
level may help identify individual conditions. However, the 
ratio of sIL-2R to LDH may also be of high distinctive value 
in assessing the state of B-cell lymphomas.  Such numerical 
data may additionally provide qualitative biological infor-
mation as well.
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